Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304

OBJECTIVE: To assess efficacy and safety of once-daily 8 or 12 mg perampanel, a noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor antagonist, when added to concomitant antiepileptic drugs (AEDs) in the treatment of drug-resistant partial-onset seizures. METHODS: Th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: French, Jacqueline A., Krauss, Gregory L., Biton, Victor, Squillacote, David, Yang, Haichen, Laurenza, Antonio, Kumar, Dinesh, Rogawski, Michael A.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2012
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3413761/
https://ncbi.nlm.nih.gov/pubmed/22843280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182635735
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
A carregar...

Registos relacionados